MYH ELISA Kits
MYH ELISA kits are specialized immunoassays designed for the quantitative detection of myosin heavy chain (MYH) proteins in various biological samples. These kits are essential tools in research areas such as muscle physiology, developmental biology, and disease pathology, where precise measurement of MYH isoforms is crucial.
Technical Overview:
MYH proteins are integral components of the contractile apparatus in muscle cells, with different isoforms (e.g., MYH1, MYH7, MYH10) playing distinct roles in muscle function and development. ELISA (Enzyme-Linked Immunosorbent Assay) kits targeting MYH proteins typically employ a sandwich assay format:
- Capture Antibody: A monoclonal or polyclonal antibody specific to the MYH isoform of interest is pre-coated onto a microplate.
- Sample Addition: Biological samples (e.g., serum, plasma, tissue homogenates) are added to the wells, allowing any MYH present to bind to the capture antibodies.
- Detection Antibody: A biotinylated detection antibody, also specific to the MYH isoform, is introduced, forming a sandwich complex.
- Enzyme Conjugate: Avidin-Horseradish Peroxidase (HRP) conjugate binds to the biotinylated detection antibody.
- Substrate Addition: A chromogenic substrate (e.g., TMB) is added, and the enzyme catalyzes a colorimetric reaction.
- Quantification: The intensity of the color change is measured spectrophotometrically, correlating with the concentration of MYH in the sample.
Applications:
- Muscle Physiology: Assessing MYH expression levels to study muscle fiber composition and adaptations in response to exercise or disease.
- Developmental Biology: Investigating the role of specific MYH isoforms during muscle development and differentiation.
- Pathology: Evaluating MYH expression in muscle-related diseases, such as cardiomyopathies or muscular dystrophies.
These kits provide researchers with reliable and specific tools to quantify MYH isoforms, facilitating advancements in understanding muscle function and related diseases.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|